PDE5A and colorectal carcinoma: Notably, the Kaplan-Meier survival analysis of patients classified into subgroups with either low or high expression of MEX3A/PDE5A proteins illustrated that CRC patients exhibiting high MEX3A and low PDE5A had the worst OS in our cohorts (Fig. 6d).